MaSTherCell announces planned investment for MaSTherCell Global of up to $25 Million to develop its global services through a strategic partnership between Orgenesis and Great Point Partners

Gosselies, Belgium – July 2, 2018. MaSTherCell, a leading Cell therapy Contract and Manufacturing Organization (CDMO), announced today a new strategic step in its corporate development.  MaSTherCell Global – a gathering of MaSTherCell (Belgium), Atvio Biotech Ltd., an Israel-based CDMO partner, and Curecell  Co. Ltd., a Korea-based CDMO partner – will beneficiate from a USD…

Continue reading "MaSTherCell announces planned investment for MaSTherCell Global of up to $25 Million to develop its global services through a strategic partnership between Orgenesis and Great Point Partners"